Deutsche Bank’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Deutsche Bank’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-591,057	Closed	-$12.4M	–	5275
2016 Q3	$12.4M	Buy	591,057 +543,597	+1,145%	+$6.26M	0.01%	1168
2016 Q2	$510K	Buy	47,460 +42,303	+820%	+$362K	﹤0.01%	3269
2016 Q1	$32K	Sell	5,157 -1,116	-18%	-$10.2K	﹤0.01%	4492
2015 Q4	$112K	Sell	6,273 -382	-6%	-$5.26K	﹤0.01%	4008
2015 Q3	$73K	Sell	6,655 -432	-6%	-$4.59K	﹤0.01%	4245
2015 Q2	$100K	Buy	7,087 +7,086	+708,600%	+$96.2K	﹤0.01%	4236
2015 Q1	$0	Sell	1 -1	-50%	-$13	﹤0.01%	6345
2014 Q4	$0	Sell	2 -32,607	-100%	-$477K	﹤0.01%	6480
2014 Q3	$248K	Buy	+32,609	New	+$254K	﹤0.01%	3949

Deutsche Bank's VTAE Position: Q4 2016 in Review

Deutsche Bank sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 591,057 shares — an estimated $12.4M sold.

Deutsche Bank first reported a position in VTAE in Q3 2014 and held it in 9 quarters. The position peaked at $12.4M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Deutsche Bank reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Deutsche Bank sold 591,057 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $12.4M.
Deutsche Bank first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q3 2014 and held it in 9 quarters.
Deutsche Bank's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $12.4M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Deutsche Bank's 13F filing for Q4 2016, filed 14 Feb 2017.